biomedicina slovenica

re="Farm Vestn" : 138-237

  1. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Isolation of beta2GPI by perchloric acid yields three protein peaks having different antigenic properties
    [Izolacija beta2GPI s perklorno kislino prinaša tri proteinske frakcije z različnimi antigenskimi lastnostmi]
    2004 ►
  2. Ambrožič Aleš; Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Prothrombin fragment 1+2 as a marker of hypercoagulable state in patients with antiphospholipid antibodies
    [Protrombinski fragment 1+2 kot označevalec hiperkoagulabilnega stanja pri bolnikih z antifosfolipidnimi protitelesi]
    2004 ►
  3. Čučnik Saša; Kveder Tanja; Božič Borut
    Paratope diversity of anti-prothrombin antibodies
    [Paratopska raznolikost protiteles proti protrombinu]
    2004 ►
  4. Božič Borut; Čučnik Saša; Ambrožič Aleš; Lestan Boris; Kos-Golja Mojca; Rozman Blaž; Kveder Tanja
    Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
    [Klinilčna občutljivost protiteles proti cikličnem citruliniranem peptidu pri bolnikih z revmatoidnim artritisom]
    2004 ►
  5. Gašperšič Nataša; Kveder Tanja; Rozman Blaž; Božič Borut
    Vpliv Ca2+ na določanje protiteles proti aneksinu V
    [Influence of calcium ions on the detection of antibodies against annexin V]
    2004 ►
  6. Melkič Enver; Piskar Majda
    Problem prisotnosti hladnih aglutininov v hematologiji
    [Problem of cold agglutinins in haematology laboratories]
    2004 ►
  7. Sešek-Briški A; Donoša C; Frahm M; Meršol A; Miklavc H; Janša R; Osredkar J
    Uporabnost 13C dihalnih testov v gastroenterologiji
    [Usefulness of 13C breath tests in gastroenterology]
    2004 ►
  8. Snoj Nada; Lenart Katarina; Božič Mojca
    Primerjalno vrednotenje testov za določanje D-dimera in ugotavljanje njihove uporabnosti pri izključevanju venske tromboze
    [Comparative evaluation of D-dimer assay and assessment of their efficiency for exclusion of deep vein thrombosis]
    2004 ►
  9. Krnjak Ljuba; Trunk Primož; Geršak Borut; Osredkar Joško
    Merjenje koncentracije proteina S100B v serumu z metodo immunoluminiscence
    [Determination of protein S100B serum concentration using immunoluminiscence assay]
    2004 ►
  10. Jerin Aleš; Požar-Lukanovič Neva; Paver-Eržen Vesna; Osredkar Joško
    Povezava med plazemsko koncentracijo interlevkina 6 in hipoksijo pri operacijah jeter
    [Association between plasma concentration of interleukin 6 and hypoxia in liver surgery]
    2004 ►
  11. Valh Renata
    Pomoč razširjenega okna detekcije pri kanabinoidih
    [The help of expanded detection window for canabinonoids determination]
    2004 ►
  12. Brečko Brigita; Fliser Eva
    Posebnosti določevanja aluminija v serumu z ETAAS-D2 žarnico
    [Speciality in determination of aluminium in serum with ETAAS-D2 lamp]
    2004 ►
  13. Zorec-Karlovšek Majda; Sollner-Dolenc Marija; Kajan Tina; Kuštrin-Samba Alenka; Skitek Milan; Zupančič Mirjana
    Določanje karbamazepina in 10-hidroksikarbazepina - metabolita oksakarbazepina v humanem serumu
    [Determination of carbamazepine and 10-hydroxycarbazepine - metabolite of oxcarbazepine in human serum]
    2004 ►
  14. Zorec-Karlovšek Majda; Sollner-Dolenc Marija; Klajderič Mateja; Kuštrin-Samba Alenka; Bregant Lev
    Odkrivanje intrauterine ekspozicije ilegalnim drogam - pomen analize mekonija
    [Detection of intrauterine ilicit drug exposure - the importance of meconium analysis]
    2004 ►
  15. Melkič Enver; Grm Lidija
    Sistem kontrole merjenja hitrosti sedimentacije eritrocitov (HSE) na analizatorju Test 1
    [Control system for measurement of ESR with Test 1 analyser]
    2004 ►
  16. Krhin B; Žitko-Krhin M; Kolenc-Peitl P; Gmeiner-Stopar T; Hojker S
    Slovenska nacionalna shema za zunanjo oceno kakovosti (SNEQAS) za področje hormonov ščitnice
    [Slovenian national external quality assessment scheme (SNEQAS) for thyroid hormones]
    2004 ►
  17. Šter Mateja; Žnidaršič Jana; Skitek Milan
    Določitev referenčnih vrednosti sedimenta in štetja celic po Stansfeld-Webbu v seču
    [Determination of reference values for the urinary sediment and counting cells by Stanfeld-Webb method]
    2004 ►
  18. Skitek Milan; Šter Mateja
    Standardizacija določanja in harmonizacija rezultatov HbA1c
    [HbA1c standardization and harmonisation]
    2004 ►
  19. Roglič Igor
    Predstavitev hospitalnega in ambulantnega programa v Kliničnem centru
    [Presentation of hospital and mabulance programmes in Clinical centre]
    2004 ►
  20. Krsnik Mladen
    Dodatne funkcionalnosti Laboratorijskega informacijskega sistema na Kliničnem inštitutu za klinično kemijo in biokemijo
    [Additional facilities of Laboratory information system in Clinical institute of clinical chemistry and biochemistry]
    2004 ►
  21. Arko Barbara; Avberšek-Lužnik Ivica; Marc Janja
    Vpliv polimorfizmov v promotorju gena za osteoprotegerin na njegovo serumsko koncentracijo pri dializnih bolnikih
    [Influence of the polymorphisms in the osteoprotegerin gene promoter on osteoprotegerin serum levels in dialysis patients]
    2004 ►
  22. Meško-Brguljan P; Cimerman N
    Is serum cystatin C a suitable marker for GFR deterioration in asthma?
    2004 ►
  23. Cvetko-Weiss V; Štrakl G; Ružič E; Jančar N; Miholič B; Marc J
    Diagnostična učinkovitost cistatina C pri oceni delovanja ledvic
    [Diagnostic efficiency of cystatin C at the renal function assessment]
    2004 ►
  24. Krivec Štefka; Šepec Petra
    Primerjava glomerulnih filtracij izra unanih preko očistka kreatinina in cistatina C
    [Comparison of glomerular filtration rate calculated from creatinine clearance and cystatin C]
    2004 ►
  25. Avberšek-Lužnik Ivica; Gaser Anuška; Pečovnik-Balon Breda; Marc Janja
    Comparison of two immunoassays for parathyroid hormone measurement in hemodialysis patients
    [Primerjava dveh imunokemijskih metod za določevanje paratiroidnega hormona pri dializnih bolnikih]
    2004 ►
  26. Malešič I; Jurjec D
    The values of aluminium in serum and hair in exposed and unexposed persons
    [Vrednosti aluminija v serumu in laseh pri izpostavljenih in neizpostavljenih osebah]
    2004 ►
  27. Zorec-Karlovšek Majda
    Analitika etanola in drugih alkoholov v telesnih tekočinah
    [Determination of ethanol and other alcohols in body fluids]
    2004 ►
  28. Černe Darko
    Toksikološka analitika v urgentni klinični biokemiji
    [Intoxication analysis in emergency medical biochemistry]
    2004 ►
  29. Gorenjak Maksimiljan
    Stopenjska toksikološka diagnostika v laboratoriju
    [Differential toxicological diagnosis in the laboratory]
    2004 ►
  30. Skitek Milan
    Experience in Slovenian national external quality assessment scheme-haematology
    2004 ►
  31. Bratož Saša; Osredkar Joško
    Ocena kakovosti rezultatov biokemijskih laboratorijev v Sloveniji
    [Quality assessment of results of Slovenian clinical chemistry laboratories]
    2004 ►
  32. Osredkar Joško
    Poslovna odličnost v laboratorijski medicini
    [EFQM model in laboratory medicine]
    2004 ►
  33. Plazar Nadja; Stegnar Mojca; Rešek-Žužek Saša; Lukač-Bajalo Jana
    Hiperhomocisteinemija pri dializnih bolnikih
    [Hypercysteinemia in hemodialysis patients]
    2004 ►
  34. Možina Barbara; Marc Janja
    Uporabnost retikulocitnih parametrov za odkrivanje hiposideremije pri hemodializnih bolnikih
    [The use of reticulocyte indices for diagnosis of iron deficiency in hemodialysis patients]
    2004 ►
  35. Avberšek-Lužnik Ivica; Marc Janja
    Biokemični kazalci patogeneze ledvične osteodistrofije
    [Biochemical markers of renal osteodystrophy]
    2004 ►
  36. Arko Barbara
    Molekularne osnove policističnih bolezni ledvic
    [Molecular basis of polycystic kidney diseases]
    2004 ►
  37. Božič Borut
    Vzroki za kronično odpoved ledvic pri sistemskih avtoimunskih boleznih
    [Reasons for chronic renal failure in systemic autoimmune disease]
    2004 ►
  38. Marc Janja
    Laboratorijska medicina pri obravnavi bolnika s kronično boleznijo
    [Laboratory medicine in management of chronic kidney disease]
    2004 ►
  39. Lukač-Bajalo Jasna
    Izvencelična DNA
    [Cell-free DNA]
    2004 ►
  40. Meško-Brguljan Pika
    Beseda gostujoče urednice
    [Guest editor's preface]
    2004 ►
  41. Peternel Luka; Stegnar Mojca
    Hemostaza pri glodalcih - povezava s predkliničnimi raziskavami novih antitrombotikov
    [Hemostasis in rodents - an association with preclinical studies of novel antithrombotics]
    2004 ►
  42. Božič Mojca; Furlan Danijela; Stegnar Mojca
    D-dimer pri izključevanju venske tromboze - katero metodo uporabiti?
    [D-dimer in exclusion of deep-vein thrombosis - which method?]
    2004 ►
  43. Pukšič Milan
    Uporaba informacijskih sistemov pri iskanju podatkov o interakcijah med zdravili
    [Use of information systems for the evaluation of adverse drug interactions]
    2004 ►
  44. Rotar-Pavlič Danica; Poplas-Susič Tonka
    Neželeni učinki protibolečinskih in protivnetnih zdravil na prebavni sistem, povezanost z analgetično nefropatijo in toksično poškodbo jeter
    2004 ►
  45. Mlinarič Aleš; Vovk Tomaž; Pavlovič Lidija
    Pomembnejše interakcije najpogosteje predpisanih nesteroidnih protivnetnih in protirevmatičnih zdravil
    [Important interactions of most frequently prescribed nonsteroidal anti-inflammatory drugs]
    2004 ►
  46. Peklar Jure
    Primerjalna analiza porabe nesteroidnih antirevmatikov pri nas in v nekaterih skandinavskih državah
    2004 ►
  47. Faganeli Nataša
    Vloga koksibov pri protibolečinski obravnavi ortopedskega bolnika
    2004 ►
  48. Markovič Saša; Bogdanovič Sanja; Mrhar Aleš
    Klinični, epidemiološki in farmakoekonomski vidiki zdravljenja resnih gastrointestinalnih zapletov pri uporabi NSAR
    [Clinical, epidemiological and pharmacoeconomical aspects of serious gastrointestinal adverse events related to NSAID therapy]
    2004 ►
  49. Bogataj Marija
    Interakcije inhibitorjev ciklooksigenaze 2 in drugih nesteroidnih antirevmatikov
    [Interactions of inhibitors of cyclooxygenase 2 and other nonsteroidal antiinflammatory drugs]
    2004 ►
  50. Praprotnik Sonja
    Sklep - tarča vnetnega in nevnetnega procesa
    2004 ►
  51. Pečar Slavko
    Inhibitorji ciklooksigenaze-2 kot antirevmatiki
    [COX-2 inhibitors as antirheumatic drugs]
    2004 ►
  52. Božič Borut
    Laboratorijska diagnostika in spremljanje revmatičnih bolezni
    [Laboratory diagnostic and monitoring of rheumatic diseases]
    2004 ►
  53. Ihan Alojz
    Etiologija in patofiziologija revmatoidnega artritisa
    [Ethiology and patophisiology of rheumatoid arthritis]
    2004 ►
  54. Gašperlin Mirjana; Štrukelj Borut
    Harmonizacija študijskih programov farmacije v Sloveniji z EU
    2004 ►
  55. Grabnar I; Bogataj M; Belič A; Karba R; Mrhar A
    Kinetics of drug distribution in the urinary bladder wall following intravesical instillation: estimation by advanced compartmental diffusion model
    2003 ►
  56. Burjak M; Bogataj M; Grabnar I; Mrhar A
    Modelling of drug release profiles from mucoadhesive microspheres adhered on urinary bladder mucosa: urodynamic model
    2003 ►
  57. Salobir Mateja; Legen Igor; Kerč Janez
    Comparison of different intestinal epithelia as models for absorption enhancement studies
    2003 ►
  58. Vovk T; Bogataj M; Roškar R; Kmetec V; Mrhar A
    The determination of main water soluble low molecular antioxidants in urinary bladder using HPLC with electrochemical detection
    2003 ►
  59. Jenko-Brinovec S; Golob M; Plaper A; Raspor P
    The genotoxicity of chromium (tris) picolinate
    2003 ►
  60. Žakelj S; Legen I; Kristl A
    The influence of HCO3--free incubation salines on rat jejunal tissue in side-by-side diffusion chambers
    2003 ►
  61. Kincl M; Turk S; Veber M; Vrečer F
    Application of Box-Behnken experimental design for characterization of drug release from prolonged release tablets
    2003 ►
  62. Krasna M; Jeras M
    Preparation of living skin substitute based on a fibrin matrix
    2003 ►
  63. Murn J; Mlinarič-Raščan I
    Modulation of apoptotic demise in B lymphoma cells
    2003 ►
  64. Herman D; Peternel P; Stegnar M; Breskvar K; Dolžan V
    The influence of CYP2C9 genotype, physiological factors and concomitant drug treatment on warfarin dose requirement
    2003 ►
  65. Bele M; Mesarič T; Planinšek O; Salobir M; Srčič S; Jamnik J
    Silica coatings on clarithromycin
    2003 ►
  66. Grandovec A; Perc S; Ocepek U
    Maillard reaction of lactose and 2-(2-aminoethoxy)-methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid, 3-ethyl 5-methyl ester maleate, a primary amine
    2003 ►
  67. Zega A; Šuštarič A; Srčič S
    Quantitative analysis of mixtures of crystalline and amorphous felodipine by near-infrared spectroscopy
    2003 ►
  68. Perišič I; Ritlop G; Grandovec A
    Development of discriminatory dissolution tests for immediate release oral dosage form
    2003 ►
  69. Ritlop G; Makuc S; Černoša L; Vrečer F
    Designing and optimisation of dissolution methods: flow-through cell as a basis for development of dissolution tests for modified release delivery oral dosage forms
    2003 ►
  70. Roškar R; Kmetec V
    A comparison of BET and GAB approach for studying moisture sorption behavior of several excipients
    2003 ►
  71. Podlogar F; Bešter-Rogač M; Gašperlin M
    Structural characterization of water - Tween 40/Imwitor 308 - isopropyl myristate microemulsions by DSC and SAXS
    2003 ►
  72. Jurkovič P; Gašperlin M
    Influence of microemulsion type and thickening on ascorbyl palmitate dermal delivery
    2003 ►
  73. Dreu R; Širca J; Pintye-Hodi K; Srčič S
    Tensile strength and disintegration time of pellets prepared by extrusion and spheronisation technology as function of different granulating liquids
    2003 ►
  74. Planinšek O; Pišek R; Vrečer F; Srčič S
    Layering of pellets with two model drugs
    2003 ►
  75. Svete Peter; Jaklič Miha T
    Does increase in tablet hardness always result in slower dissolution rate?
    2003 ►
  76. Mateović T; Bogataj M; Ratnik M; Mrhar A
    Dependance of microspheres solidification time on initial temperature in solvent evaporation process
    2003 ►
  77. Leskošek T; Vrečer F; Pišek R
    The study of influence of disintegrant amount and type on physico-technological properties of the pellets produced in a high shear mixer
    2003 ►
  78. Pišek R; Ritlop G; Krošelj V; Kramar A; Vrečer F
    The influence of matrix composition and hydrophilic coating on dissolution properties of model drug
    2003 ►
  79. Kotar-Jordan B; Grčman M; Ograjšek N; Vrečer F
    Solid state characterization of new pantoprazole sodium hydrate forms and its amorphous form
    2003 ►
  80. Zupančič V; Kotar-Jordan B; Grčman M; Ograjšek N; Vrečer F
    Characterization of two pantoprazole sodium hydrates
    2003 ►
  81. Zajc N; Obreza A; Srčič S
    Physical stability of nifedipine solid dispersions prepared by hot melt method - a DSC and MTDSC study
    2003 ►
  82. Tivadar A; Kočevar K; Muševič I; Kerč J; Srčič S
    Study of felodipine transformation from glassy to crystalline state
    2003 ►
  83. Tivadar A; Kočevar K; Muševič I; Srčič S
    Surface analysis of polymer films by atomic force microscopy
    2003 ►
  84. Bešter-Rogač M; Rus L; Srčič S
    Volumetric characterization of some dihydropyridine derivates
    2003 ►
  85. Vajs A; Smrkolj M; Sitar-Čurin A; Grčman M
    Study of polymorphism of 1-cyclopropyl-6-fluoro-1,4-dihydro-8-metoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
    2003 ►
  86. Ferlan A; Punčuh-Kolar A
    Some aspects of reducing drug particle size
    2003 ►
  87. Preskar M; Punčuh-Kolar A; Planinšek O; Vrečer F
    Study of the influence of formulation and process variables onto dissolution kinetics of granules and tablets
    2003 ►
  88. Preskar M; Punčuh-Kolar A; Vrečer F
    Study of influence of particle size and powder surface area on the technological relevant properties of model drug KD-9102
    2003 ►
  89. Mlinarič-Raščan I
    Thiopurine methyltransferase pharmacogenetics
    2003 ►
  90. Jeras M; Maličev E; Radosavljevič D; Knežević M; Kregar-Velikonja N
    Selected biocompatible and biodegradable matrices as templated for in vitro preparation of implantable human living cartilage tissue substitutes
    2003 ►
  91. Planinšek O; Bele M; Kunaver M; Zadnik J; Srčič S
    Influence of particle formation route on lactose physicochemical properties
    2003 ►
  92. Baumgartner S; Slameršek V; Kristl J
    Controlled drug delivery of hydrophilic drugs from cellulose ether matrix tablets: the influence of the drug molecule size on its release mechanism and kinetics
    2003 ►
  93. Cegnar Mateja; Premzl Aleš; Zavašnik-Bergant Valentina; Kristl Julijana; Kos Janko
    Effect of polymer type on the activity of cystatin encapsulated in poly(lactide-co-glycolide) nanoparticles and their uptake in MCF-10A neoT cells
    2003 ►
  94. Fočo Alma; Kristl Julijana
    Formulation and evaluation of liposomes as carriers for sodium ascorbyl phosphate into the skin
    2003 ►
  95. Legen Igor; Kristl Albin
    Multidrug resistance associated protein 2 (MRP2) activity in the rat small intestine in vitro
    2003 ►
  96. Kerec M; Bogataj M; Veranič P; Mrhar A
    The role of calcium ions in the mechanism of chitosan enhanced drug permeability into the pig urinary bladder wall
    2003 ►
  97. Bohanec Simona
    Experimental design as a tool for preformulation studies
    2003 ►
  98. Pišek Robert
    Macroscopic physical properties of powders and granules
    2003 ►
  99. Planinšek Odon
    Surface characterization of solid materials
    2003 ►
  100. Vrečer F
    Polymorphism and pseudopolymorphism
    2003 ►

   1 38 138 238 338 438 538 638 738 838  

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko